- Home
- REI vs TARA Comparison
REI vs TARA Comparison
Compare REI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- TARA
- Stock Information
- Founded
- REI 2004
- TARA N/A
- Country
- REI United States
- TARA United States
- Employees
- REI N/A
- TARA N/A
- Industry
- REI Oil & Gas Production
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REI Energy
- TARA Health Care
- Exchange
- REI Nasdaq
- TARA Nasdaq
- Market Cap
- REI 206.5M
- TARA 165.5M
- IPO Year
- REI N/A
- TARA N/A
- Fundamental
- Price
- REI $0.94
- TARA $6.61
- Analyst Decision
- REI
- TARA Strong Buy
- Analyst Count
- REI 0
- TARA 7
- Target Price
- REI N/A
- TARA $20.33
- AVG Volume (30 Days)
- REI 2.0M
- TARA 485.7K
- Earning Date
- REI 11-06-2025
- TARA 11-10-2025
- Dividend Yield
- REI N/A
- TARA N/A
- EPS Growth
- REI N/A
- TARA N/A
- EPS
- REI N/A
- TARA N/A
- Revenue
- REI $308,790,652.00
- TARA N/A
- Revenue This Year
- REI N/A
- TARA N/A
- Revenue Next Year
- REI $6.98
- TARA N/A
- P/E Ratio
- REI N/A
- TARA N/A
- Revenue Growth
- REI N/A
- TARA N/A
- 52 Week Low
- REI $0.72
- TARA $2.21
- 52 Week High
- REI $1.62
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- REI 44.50
- TARA 72.67
- Support Level
- REI $0.92
- TARA $5.00
- Resistance Level
- REI $0.99
- TARA $6.85
- Average True Range (ATR)
- REI 0.05
- TARA 0.48
- MACD
- REI -0.00
- TARA 0.16
- Stochastic Oscillator
- REI 23.10
- TARA 90.51
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).